Ivan Amaro-Ferraz

Santa Cruz De Tenerife, CN, Spain

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 196 publications

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Interleukin-2 is associated with cytopenias in systemic lupus erythematosus.

Journal: Autoimmunity

Published: July 25, 2026

The Effectiveness of Janus Kinase Inhibitors for the Management of Relapsing Takayasu Arteritis: A Spanish Real-World Study and Comprehensive Review of the Literature.

The Effectiveness of Janus Kinase Inhibitors for the Management of Relapsing Takayasu Arteritis: A Spanish Real-World Study and Comprehensive Review of the Literature.

Journal: Life (Basel, Switzerland)

Published: May 14, 2026

Ultrasensitive serum interferon alpha equals interferon signatures as a marker of lupus disease activity.

Ultrasensitive serum interferon alpha equals interferon signatures as a marker of lupus disease activity.

Journal: iScience

Published: April 15, 2026

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.

Window of opportunity with abatacept in Rheumatoid arthritis-associated interstitial lung disease: A multicentre study of 526 patients.

Journal: European journal of internal medicine

Published: April 01, 2026

Cardiovascular-Kidney-Metabolic syndrome predicts the development of cardiovascular events in patients with rheumatoid arthritis: a 10-years prospective analysis from the CARMA cohort.

Cardiovascular-Kidney-Metabolic syndrome predicts the development of cardiovascular events in patients with rheumatoid arthritis: a 10-years prospective analysis from the CARMA cohort.

Journal: Seminars in arthritis and rheumatism

Published: February 25, 2026

Serum interleukin-2 levels associate with disease activity and cardiovascular risk in patients with rheumatoid arthritis.

Serum interleukin-2 levels associate with disease activity and cardiovascular risk in patients with rheumatoid arthritis.

Journal: Clinical and experimental rheumatology

Published: February 03, 2026

Ethnic differences in disease activity among patients with systemic lupus erythematosus in a universal public healthcare system.

Ethnic differences in disease activity among patients with systemic lupus erythematosus in a universal public healthcare system.

Journal: Lupus

Published: January 28, 2026

Incidence and clinical features of ANCA-associated vasculitis before and during the COVID-19 pandemic: experience from a single-center in Northern Spain.

Incidence and clinical features of ANCA-associated vasculitis before and during the COVID-19 pandemic: experience from a single-center in Northern Spain.

Journal: Frontiers in medicine

Published: December 12, 2025

Hepatotoxicity Risk of Isoniazid in Patients with Autoimmune Rheumatic Diseases and Prior Liver Injury Due to Disease-Modifying Antirheumatic Drugs: A Single-Center Experience and Literature Review.

Hepatotoxicity Risk of Isoniazid in Patients with Autoimmune Rheumatic Diseases and Prior Liver Injury Due to Disease-Modifying Antirheumatic Drugs: A Single-Center Experience and Literature Review.

Journal: Journal of clinical medicine

Published: November 23, 2025

Serum IL-2 levels are associated with disease activity and related to dyslipidaemia and the immunological profile in systemic lupus erythematosus.

Serum IL-2 levels are associated with disease activity and related to dyslipidaemia and the immunological profile in systemic lupus erythematosus.

Journal: Lupus science & medicine

Published: November 03, 2025

Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort.

Disease activity and hyperuricemia predict the development of cardiovascular events in patients with Psoriatic Arthritis: results of the 10-year prospective evaluation in the CARMA cohort.

Journal: Seminars in arthritis and rheumatism

Published: October 12, 2025

Clinical and serological associations of interferon-α and interferon-γ in rheumatoid arthritis patients.

Clinical and serological associations of interferon-α and interferon-γ in rheumatoid arthritis patients.

Journal: Rheumatology (Oxford, England)

Published: October 01, 2025

Showing 1-12 of 196

Last Updated: 09/26/2026